The purpose of the proposed project is to obtain tumors and other tissues and (a) make them available in a form (frozen fresh, minced in sterile culture medium, etc.) specified by cancer researchers and of as high quality as possible while (b) assuring that the tissues distributed have been very thoroughly characterized diagnostically. The pathologists who will run this service include Dr. K. DeSchryver, the newly arrived Head of Anatomic Pathology (includes both surgical and autopsy pathology) at CWRU; Dr. F. W. Abdul-Karim, a pathologist who is and has been since its inception Co-Director of the current Tissue Conservation Core Facility (TisCon CF) at CWRU; and Dr. T. G. Pretlow, the Principal Investigator and Co-Director for the TisCon CF at CWRU. Dr. Pretlow has started and run two such services in cancer centers at CWRU (1987-1990) and at the Univ. of Ala. at Birmingham (1978-1983). All three of these pathologists function in both surgical and autopsy pathology at CWRU. As will be apparent from their lists of publications, they use human tissues for research. All have a need for this service for their research, understand the importance of quality of tissue obtained for research, and understand the need to satisfy diagnostic requirements with the highest possible standards. CWRU offers several tactical advantages as a location for this service: (a) there is at CWRU a large hospital for children and a large hospital for adults both of which have large oncology services; (b) within a 2-mile radius of CWRU, there is an almost unique availability of large amounts of tissues in a small geographical area in several neighboring hospitals that have agreed to participate, i.e., almost 80,000 surgical specimens/year and 1,100 autopsies/year within a 2-mile radius; (c) within a 10-mile radius, there are over 130,000 surgical specimens in hospitals that have agreed to cooperate; (d) within successively larger radii, there are much larger numbers of surgically resected tissues in hospitals that have agreed to cooperate (more than 300,000 surgically resected tissues) if the need for rare tumors is not satisfied by closer hospitals; (e) among these hospitals, there are 3 childrens hospitals and other hospitals with pediatric oncology services; and (f) there is a geographically based cancer registry that covers all of Cuyahoga County (Cleveland and contiguous suburbs) that has an excellent record of follow-up of cancer patients for many years. Most of the physicians and pathologists at the hospitals within a radius of 0-2 miles have appointments at the medical school and col- laborate with the medical school in teaching and in the care of patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA054031-02
Application #
3549792
Study Section
Special Emphasis Panel (SRC (46))
Project Start
1991-01-01
Project End
1995-12-31
Budget Start
1992-01-01
Budget End
1992-12-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Hao, X P; Pretlow, T G; Rao, J S et al. (2001) Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res 61:8085-8
Hao, X P; Willis, J E; Pretlow, T G et al. (2000) Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. Cancer Res 60:18-21
Siu, I M; Robinson, D R; Schwartz, S et al. (1999) The identification of monoclonality in human aberrant crypt foci. Cancer Res 59:63-6
Dawson, D M; Lawrence, E G; MacLennan, G T et al. (1998) Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer. J Natl Cancer Inst 90:519-23
Herman, W H; Emancipator, S N; Rhoten, R L et al. (1998) Vascular and glomerular expression of endothelin-1 in normal human kidney. Am J Physiol 275:F8-17
Pretlow, T P; Pretlow, T G (1998) Putative preneoplastic changes identified by enzyme histochemical and immunohistochemical techniques. J Histochem Cytochem 46:577-83
Cheng, L; Sun, J; Pretlow, T G et al. (1996) CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapy. J Natl Cancer Inst 88:607-11
Konstantakos, A K; Siu, I M; Pretlow, T G et al. (1996) Human aberrant crypt foci with carcinoma in situ from a patient with sporadic colon cancer. Gastroenterology 111:772-7
Eshleman, J R; Lang, E Z; Bowerfind, G K et al. (1995) Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. Oncogene 10:33-7
Pretlow, T G (1994) Correspondence re: Tatusuo Tomita, Timothy Dalton, Simon Kwok, Saing Lee, Mark Noble, and Masahiro Chiga. Profile of prostatic-specific antigen in prostatic carcinomas. Mod Pathol 6:259, 1993. Mod Pathol 7:146-8

Showing the most recent 10 out of 13 publications